Concurrent Chemoradiation in Anal Cancer Patients Delivered with Bone Marrow-Sparing IMRT: Final Results of a Prospective Phase II Trial

We investigated the role of the selective avoidance of haematopoietically active pelvic bone marrow (BM), with a targeted intensity-modulated radiotherapy (IMRT) approach, to reduce acute hematologic toxicity (HT) in anal cancer patients undergoing concurrent chemo-radiation. We designed a one-armed...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Pers Med
Autori principali: Arcadipane, Francesca, Silvetti, Patrick, Olivero, Francesco, Gastino, Alessio, Carlevato, Roberta, Chiovatero, Ilaria, Spinelli, Lavinia, Mistrangelo, Massimiliano, Cassoni, Paola, Ritorto, Giuliana, Gallio, Elena, Lesca, Adriana, Faletti, Riccardo, Giglioli, Francesca Romana, Fiandra, Christian, Ricardi, Umberto, Franco, Pierfrancesco
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8157357/
https://ncbi.nlm.nih.gov/pubmed/34069862
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11050427
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi